Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 19/20 | 1.00 |
| ▸ | TACR2 | P21452 | 2/20 | 0.70 |
| ▸ | TACR3 | P29371 | 2/20 | 0.70 |
| ▸ | CCR5 | P51681 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7751634 | 0.99 | TACR1 (0.98) | TACR1TACR2TACR3CCR5 | |
| SCHEMBL8300343 | 0.86 | TACR1 (0.75) | TACR1TACR2TACR3CCR5 | |
| SCHEMBL8298555 | 0.86 | TACR1 (0.75) | TACR1TACR2TACR3CCR5 | |
| SCHEMBL7770397 | 0.86 | TACR1 (0.75) | TACR1TACR2TACR3CCR5 | |
| Hydrochloric Acid SCHEMBL8742817 | 0.86 | TACR1 (0.74) | TACR1TACR2TACR3CCR5 | |
| SCHEMBL4765370 | 0.85 | TACR1 (0.75) | TACR1TACR2TACR3CCR5 | |
| Hydrochloric Acid SCHEMBL8742480 | 0.85 | TACR1 (0.74) | TACR1TACR2TACR3 | |
| Hydrochloric Acid SCHEMBL8483004 | 0.85 | TACR1 (0.74) | TACR1TACR2TACR3CCR5 | |
| Hydrochloric Acid SCHEMBL7750066 | 0.85 | TACR1 (0.73) | TACR1TACR2TACR3CCR5 | |
| SCHEMBL8300814 | 0.84 | TACR1 (0.73) | TACR1TACR2TACR3CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0673928-B1 | Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists | SANOFI SYNTHELABO (FR) | 2001-08-29 | — | — | EP | disclosed |
| EP-0673928-A1 | Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists | SANOFI (FR) | 1995-09-27 | — | — | EP | disclosed |